Abstract
We have previously documented that octreotide therapy suppresses sweating and palpitations in patients with the postural tachycardia syndrome. We now report that octreotide also suppresses these and related symptoms in patients with postmenopausal hot flushes.
MeSH terms
-
Antineoplastic Agents, Hormonal / administration & dosage*
-
Antineoplastic Agents, Hormonal / adverse effects
-
Colic / chemically induced
-
Diarrhea / chemically induced
-
Dose-Response Relationship, Drug
-
Female
-
Hot Flashes / drug therapy*
-
Humans
-
Injections, Subcutaneous
-
Octreotide / administration & dosage*
-
Octreotide / adverse effects
-
Placebos
-
Postmenopause
Substances
-
Antineoplastic Agents, Hormonal
-
Placebos
-
Octreotide